Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory T Wolf

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
JAMA Network Open|August 9, 2021
Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal CancerLauren J Beesley, Andrew G Shuman, Michelle L Mierzwa, et al.
Head & Neck|August 22, 2012
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerShamir P Chandarana, Julia S Lee, Eric J P Chanowski, et al.
Head & Neck|September 17, 2009
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
Head & Neck|February 2, 2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancerGregory T Wolf, Willard E Fee, Robert W Dolan, et al.
Auris, Nasus, Larynx|July 12, 2016
Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trialsAlvaro Sanabria, Aline L F Chaves, Luiz P Kowalski, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 4, 2013
Is open surgery for head and neck cancers truly declining?Dana M Hartl, Daniel F Brasnu, Jatin P Shah, et al.
Head & Neck|September 25, 2014
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinomaMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
JAMA Network Open|August 9, 2021
Development and Assessment of a Model for Predicting Individualized Outcomes in Patients With Oropharyngeal CancerLauren J Beesley, Andrew G Shuman, Michelle L Mierzwa, et al.
Head & Neck|August 22, 2012
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerShamir P Chandarana, Julia S Lee, Eric J P Chanowski, et al.
Head & Neck|September 17, 2009
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
Head & Neck|February 2, 2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancerGregory T Wolf, Willard E Fee, Robert W Dolan, et al.
Auris, Nasus, Larynx|July 12, 2016
Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trialsAlvaro Sanabria, Aline L F Chaves, Luiz P Kowalski, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 4, 2013
Is open surgery for head and neck cancers truly declining?Dana M Hartl, Daniel F Brasnu, Jatin P Shah, et al.
Head & Neck|September 25, 2014
Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinomaMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Pageof 22